Business · Companies · 5 hrs ago

Russian regulator orders Grotex to pay 2bn rubles over patent violation

Russian regulator orders Grotex to pay 2bn rubles over patent violation

Russia’s antitrust regulator ordered drugmaker Grotex to pay 2 billion rubles to the federal budget, saying the money was illegally earned.

The regulator said Grotex broke competition law by selling Emforix, a generic medicine for type 2 diabetes, before the patent on the original drug expired.

It also said Grotex did not get the patent holder’s consent.

The patent covers empagliflozin, the medicine’s active ingredient, and is due to expire in November 2029.

The case began after a complaint from Boehringer Ingelheim and a representative of the patent holder.

Grotex must stop the violation and transfer the money to the federal budget, as the regulator ordered.

1 source

Related

What people are saying

Federal Antimonopoly ServiceCompetition regulator
The Federal Antimonopoly Service of Russia recognized the pharmaceutical company as having violated the Law on Protection of Competition and issued a binding order to stop the violation and transfer to the federal budget illegally obtained income of 2 billion rubles.
via Vedomosti